SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego drugmaker Orexigen Therapeutics Inc. announced May 27 that Dr. Eckard Weber, the company’s co-founder and former chairman, has resigned from the board of directors.
Phoenix House California named Shawna Morris its executive director over the nonprofit's California locations, including Phoenix House San Diego.
The U.S. Department of Justice on Wednesday announced that it has filed a Medicare-fraud lawsuit against Prime Healthcare Services Inc. of Ontario, which owns Alvarado Hospital in San Diego, where a whistleblower complaint initiated an investigation.
FINANCE: Xanthopoulos Brings Leadership, Focus And Location to Companies
The growth of San Diego’s biotech hub is often credited to a small but active pool of “serial entrepreneurs.” As the historically vibrant ecosystem begins to dim in a down market, a few bold individuals with enough cash or clout to refuel the sector become increasingly valuable.
DRUGS: Tougher Times in Pharma Add to Challenges
Avalon Ventures LLC is launching an additional startup out of its venture capital incubator in La Jolla. The firm, called PDI Therapeutics Inc., is jointly backed by British drugmaker GlaxoSmithKline plc and San Diego’s Avalon as part of an ongoing partnership.
Qualcomm Life, the San Diego healthtech subsidiary of Qualcomm Inc., is teaming up with Medtronic Plc to develop disposable glucose monitoring systems for type 2 diabetes patients.
Advanced materials able to withstand extreme environments are the focus of a new binational institute inaugurated May 24.
La Jolla’s Innovus Pharmaceuticals Inc., a commercial-stage drug company that makes over-the-counter medicine, has acquired Austin, Texas-based Beyond Human for $630,000 in cash.
San Diego skin care firm MDRejuvena Inc. has appointed Randy Kriech as president and CEO of the company.
San Diego-based Mesa Biotech Inc., a privately held, molecular diagnostic company, announced the appointment of Tom Willardson as chief financial officer and John Monroe as senior vice president of operations.
These are uneasy days for biotech CFOs. Valuations are down, capital is harder to come by, and companies (fearful they will be undervalued) are shying away from acquisition talks.
One of San Diego County’s biggest drugmakers is teaming up with a cancer center in Texas to tackle new strategies in oncology.
BIOTECH: Key Resource Offered in Co.’s Lab Rentals
Two entrepreneurs in San Diego are applying “sharing economy” principles to a new frontier: science.
San Diego-based OncoSec Medical Inc. will sell about $10 million of its common stock to a single health care institutional fund, the company announced Monday.